MeiraGTx Holdings (MGTX) Interest Coverage Ratio Growth (1y) (2018 - 2025)
MeiraGTx Holdings (MGTX) Interest Coverage Ratio Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -347.04% |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | 73.00% |
| 10 | MeiraGTx Holdings | 1.02 Bn | 950.30 Mn | - | 138.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.37% |
| Sep 30, 2025 | -28.24% |
| Jun 30, 2025 | 14.42% |
| Mar 31, 2025 | 67.76% |
| Dec 31, 2024 | -740.03% |
| Sep 30, 2024 | -20.91% |
| Jun 30, 2024 | -74.15% |
| Mar 31, 2024 | -38.66% |
| Dec 31, 2023 | 122.97% |
| Sep 30, 2023 | 19.62% |
| Jun 30, 2023 | 50.71% |
| Mar 31, 2023 | 50.51% |
| Dec 31, 2022 | -643.01% |
| Sep 30, 2022 | 34.04% |
| Jun 30, 2022 | -6.90% |
| Mar 31, 2022 | -12.90% |
| Dec 31, 2021 | 100.62% |
| Sep 30, 2021 | -3,470.37% |
| Jun 30, 2021 | -844.00% |
| Mar 31, 2021 | -1,969.96% |